Saito O, Aoyagi M, Tojima H, Koike Y
Department of Otolaryngology, Yamagata University School of Medicine, Japan.
Acta Otolaryngol Suppl. 1994;511:153-5. doi: 10.3109/00016489409128322.
The method of detecting diabetes mellitus and estimating the diabetic control status in patients with Bell's palsy, and the effect of high-dose steroid therapy for Bell's palsy accompanied by diabetes were investigated. From October 1987, hemoglobin A1c (HbA1c) was introduced to detect diabetes in 288 out of 372 patients with Bell's palsy, as a screening test for DM. Thirty-six diabetics with complete facial palsy were treated by high dose steroid therapy as described by Stennert. Hemoglobin A1c was useful in diagnosing diabetes and in assessing the diabetic control. Many patients under diabetic therapy kept their diabetes under good control. In cases of complete palsy, high-dose steroid therapy, at a cure rate of 97.4%, was highly effective in treating diabetes-accompanied Bell's palsy.
研究了贝尔麻痹患者中糖尿病的检测方法及糖尿病控制状态的评估方法，以及大剂量类固醇疗法对伴有糖尿病的贝尔麻痹的疗效。自1987年10月起，对372例贝尔麻痹患者中的288例采用糖化血红蛋白（HbA1c）作为糖尿病的筛查试验来检测糖尿病。36例完全性面瘫的糖尿病患者接受了施泰纳特所描述的大剂量类固醇疗法。糖化血红蛋白有助于诊断糖尿病和评估糖尿病控制情况。许多接受糖尿病治疗的患者血糖控制良好。在完全性面瘫的病例中，大剂量类固醇疗法治疗伴有糖尿病的贝尔麻痹疗效显著，治愈率为97.4%。
